News
Vimseltinib is the first and only therapy with marketing authorization for the treatment of TGCT in the European UnionOSAKA, ...
TEAM Technologies (“TEAM Tech”), a leading end-to-end outsourced manufacturer of mission-critical medical devices, announces ...
Genomines’ platform produces plant-sourced battery-grade nickel faster, cheaper, and cleaner than traditional methodsEarly ...
Keensight Capital ("Keensight"), one of the leading private equity managers dedicated to pan-European Growth Buyout [1] ...
SAN FRANCISCO, CA AND BRENTWOOD, TN / ACCESS Newswire / September 17, 2025 / Ardent Health, a leading provider of healthcare ...
Medincell (Paris:MEDCL):Data from the completed phase 3 SOLARIS trial to be presented at the 2025 Psych Congress Annual ...
Parker Moffa, Chief Operating Officer announced today the official launch of Freight Linq, a modern freight brokerage firm ...
Upperton Pharma Solutions has added another impressive award to a growing list of achievements, winning the award for Pharma ...
NEW YORK CITY, NY / ACCESS Newswire / September 17, 2025 / Visionary Holdings Inc. (NASDAQ:GV) ("GV" or the "Company"), a ...
Enveric Biosciences, Inc. (NASDAQ: ENVB) (“Enveric” or the “Company”), a biotechnology company advancing next-generation ...
Seasoned Leadership Joins to Support Growth and R&D and Meet Demand for Continuous Care Solution in Retinal DiseaseRALEIGH, N ...
Crown Bioscience Expands US Presence with New Model Development Center in Kannapolis, North Carolina
Crown Bioscience, a global contract research organization (CRO) headquartered in the United States and part of JSR Life ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results